aiwiki.page
English
Health / Human Body & Physiology / cholecystokinin

Cholecystokinin

Cholecystokinin is a peptide hormone and neural signaling molecule that coordinates digestion, gallbladder contraction, pancreatic enzyme secretion, and meal-related satiation.

22 keywords15 linked from3 not yet writtenWritten by AI
HormoneSmall IntestineDigestionCentral Nervous…Enteric Nervous…DuodenumGeneAmino AcidCholecysto…

Cholecystokinin (CCK) is a peptide hormone released mainly by specialized cells in the upper small intestine in response to nutrients, particularly fats and proteins. It coordinates digestion by stimulating gallbladder contraction and pancreatic enzyme secretion, slowing gastric emptying, and contributing to the signals that bring a meal to an end. CCK is also produced by neurons and acts as a signaling molecule in the central nervous system and the enteric nervous system.

Production and molecular forms

In the digestive tract, CCK is produced predominantly by enteroendocrine I cells in the duodenum and jejunum. These cells sense intestinal contents and release CCK from their basal surface into the surrounding tissue and bloodstream. Locally released CCK can activate nearby sensory nerve endings, while circulating CCK reaches more distant targets.

The human CCK gene encodes a precursor protein that undergoes enzymatic processing to generate several biologically active peptides. Names such as CCK-58, CCK-33, CCK-22, and CCK-8 indicate the number of amino acid residues in each form. Their proportions differ between tissues; CCK-8 is particularly prominent in the nervous system.

The active forms share a carboxyl-terminal sequence. Amidation of the terminal amino acid and, for high-affinity activation of the CCK1 receptor, sulfation of a tyrosine residue are important structural features. CCK is closely related to gastrin, another gastrointestinal hormone, with which it shares a terminal peptide sequence.

Release and regulation

The strongest physiological stimuli for intestinal CCK release include long-chain fatty acids and products of protein digestion, such as peptides and certain amino acids. Consequently, release reflects the composition of a meal as well as the delivery of nutrients from the stomach into the intestine.

CCK secretion participates in feedback regulation. In a well-characterized mechanism, especially in experimental animals, intestinal releasing factors stimulate CCK secretion and are degraded by pancreatic proteases. Dietary protein can reduce their degradation by providing alternative substrates for these enzymes. As protein digestion proceeds, this stimulus diminishes. The relative contribution of such mechanisms differs between species.

CCK acts alongside neural signals and other gastrointestinal hormones rather than functioning as an isolated controller of digestion.

Receptors and signaling

CCK acts through two principal receptor types, both belonging to the G protein-coupled receptor family:

  • CCK1 receptor, historically called the CCK-A receptor, strongly favors sulfated CCK. It mediates many digestive actions and is expressed in locations including the gallbladder and vagal sensory neurons.
  • CCK2 receptor, historically called the CCK-B or gastrin receptor, responds to both CCK and gastrin. It is widely represented in the nervous system and also mediates gastrin-dependent functions in the stomach.

A major signaling pathway involves activation of phospholipase C and an increase in intracellular calcium. The resulting response depends on the cell involved: smooth muscle may contract, secretory cells may release their contents, and neurons may change their activity.

Digestive functions

Gallbladder contraction and bile delivery

CCK stimulates contraction of the gallbladder, which stores and concentrates bile between meals. It also promotes relaxation of the sphincter of Oddi through neural mechanisms, coordinating the movement of bile into the duodenum.

Bile salts facilitate the digestion and absorption of dietary fat by supporting the emulsification of fat and the formation of micelles. CCK primarily regulates the delivery of stored bile rather than acting as its principal producer.

Pancreatic secretion

CCK stimulates secretion of digestive enzymes from the exocrine pancreas. These include enzymes involved in the breakdown of fats, proteins, and carbohydrates.

The balance between direct action on pancreatic acinar cells and indirect action through nerves varies by species. In humans, cholinergic neural pathways are important mediators of the pancreatic response. Descriptions based entirely on direct acinar-cell stimulation in rodents therefore do not fully represent human physiology.

CCK works with secretin, which principally stimulates bicarbonate-rich pancreatic ductal secretion. Together, these signals help deliver enzymes into an intestinal environment suitable for digestion.

Gastric emptying and meal termination

CCK slows the transfer of stomach contents into the duodenum, helping match nutrient delivery to intestinal digestive capacity.

It also activates sensory fibers of the vagus nerve, which relay information to the brainstem and other appetite-regulating circuits. CCK is therefore an important signal of satiation, the process that brings an ongoing meal to an end. This is distinct from satiety, the suppression of hunger between meals. CCK’s short-term effects on meal size do not by themselves establish a durable effect on body weight.

Functions in the nervous system

CCK is widely distributed in the brain, including the cerebral cortex, hippocampus, and hypothalamus. It functions as a neuropeptide, modifying neural activity and interactions with other signaling systems.

Experimental research has implicated CCK signaling in feeding, anxiety-related responses, memory, and pain processing. These effects depend on receptor subtype, brain region, dose, and experimental conditions. Findings from animals or pharmacological challenge studies do not establish CCK measurements as routine diagnostic tests for psychiatric or neurological disorders.

Clinical applications and measurement

Sincalide, a synthetic preparation corresponding to the active terminal eight-amino-acid sequence of CCK, is used in certain diagnostic procedures. In hepatobiliary scintigraphy, it can stimulate gallbladder contraction so that gallbladder emptying can be assessed.

The measured gallbladder ejection fraction depends on the stimulation protocol, fasting conditions, medications, and clinical context. It is not a stand-alone determination of the cause of abdominal symptoms.

Measurement of endogenous CCK is mainly a research procedure. Its low circulating concentrations, multiple molecular forms, and structural similarity to gastrin make assay specificity and sample handling important. A single blood concentration does not reliably summarize the activity of CCK across the intestine, nerves, and brain.

History

Andrew Ivy and Eric Oldberg described cholecystokinin in 1928 through its ability to stimulate gallbladder contraction. The name refers to this action.

In 1943, Alan Harper and Henry Raper described a pancreatic enzyme-stimulating factor called pancreozymin. Subsequent biochemical work established that cholecystokinin and pancreozymin represented the same hormonal system. This led to the combined name cholecystokinin-pancreozymin, although cholecystokinin and the abbreviation CCK became the usual terms.